Articles with public access mandates - Uri BarashLearn more
Not available anywhere: 2
Targeting heparanase to the mammary epithelium enhances mammary gland development and promotes tumor growth and metastasis
I Boyango, U Barash, L Fux, I Naroditsky, N Ilan, I Vlodavsky
Matrix Biology 65, 91-103, 2018
Mandates: US National Science Foundation
Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression
M Gross-Cohen, Y Yanku, O Kessler, U Barash, I Boyango, A Cid-Arregui, ...
Matrix Biology 99, 58-71, 2021
Mandates: Helmholtz Association
Available somewhere: 27
Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis
U Barash, V Cohen‐Kaplan, I Dowek, RD Sanderson, N Ilan, I Vlodavsky
The FEBS journal 277 (19), 3890-3903, 2010
Mandates: US National Institutes of Health
Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock
G Arad, R Levy, I Nasie, D Hillman, Z Rotfogel, U Barash, E Supper, ...
PLoS biology 9 (9), e1001149, 2011
Mandates: US National Institutes of Health
Heparanase enhances myeloma progression via CXCL10 downregulation
U Barash, Y Zohar, G Wildbaum, K Beider, A Nagler, N Karin, N Ilan, ...
Leukemia 28 (11), 2178-2187, 2014
Mandates: US National Institutes of Health
Targeting heparanase in cancer: inhibition by synthetic, chemically modified, and natural compounds
CD Mohan, S Hari, HD Preetham, S Rangappa, U Barash, N Ilan, ...
Iscience 15, 360-390, 2019
Mandates: US National Science Foundation, US National Institutes of Health
Heparanase Cooperates with Ras to Drive Breast and Skin Tumorigenesis
I Boyango, U Barash, I Naroditsky, JP Li, E Hammond, N Ilan, I Vlodavsky
Cancer Research 74 (16), 4504-4514, 2014
Mandates: US National Institutes of Health
Specific inhibition of heparanase by a glycopolymer with well-defined sulfation pattern prevents breast cancer metastasis in mice
RS Loka, ET Sletten, U Barash, I Vlodavsky, HM Nguyen
ACS applied materials & interfaces 11 (1), 244-254, 2018
Mandates: US National Institutes of Health
Identification of novel class of triazolo-thiadiazoles as potent inhibitors of human heparanase and their anticancer activity
CP Baburajeev, CD Mohan, S Rangappa, DJ Mason, JE Fuchs, A Bender, ...
BMC cancer 17, 1-14, 2017
Mandates: Department of Science & Technology, India
A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics
U Barash, V Cohen-Kaplan, G Arvatz, S Gingis-Velitski, F Levy-Adam, ...
The FASEB Journal 24 (4), 1239, 2010
Mandates: US National Institutes of Health
Involvement of heparanase in the pathogenesis of mesothelioma: basic aspects and clinical applications
U Barash, M Lapidot, Y Zohar, C Loomis, A Moreira, S Feld, C Goparaju, ...
JNCI: Journal of the National Cancer Institute 110 (10), 1102-1114, 2018
Mandates: US National Science Foundation, US National Institutes of Health
Heparanase 2 attenuates head and neck tumor vascularity and growth
M Gross-Cohen, S Feld, I Doweck, G Neufeld, P Hasson, G Arvatz, ...
Cancer research 76 (9), 2791-2801, 2016
Mandates: US National Science Foundation, US National Institutes of Health
Post-transcriptional regulation of heparanase gene expression by a 3′ AU-rich element
G Arvatz, U Barash, O Nativ, N Ilan, I Vlodavsky
The FASEB Journal 24 (12), 4969, 2010
Mandates: US National Institutes of Health
Heparanase promotes glioma progression via enhancing CD24 expression
U Barash, A Spyrou, P Liu, E Vlodavsky, C Zhu, J Luo, D Su, N Ilan, ...
International journal of cancer 145 (6), 1596-1608, 2019
Mandates: US National Science Foundation, National Natural Science Foundation of China
Heparanase and chemotherapy synergize to drive macrophage activation and enhance tumor growth
U Bhattacharya, L Gutter-Kapon, T Kan, I Boyango, U Barash, SM Yang, ...
Cancer research 80 (1), 57-68, 2020
Mandates: US National Science Foundation, US National Institutes of Health, National …
Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and In Vivo Tumor Growth
A Spyrou, S Kundu, L Haseeb, D Yu, T Olofsson, K Dredge, E Hammond, ...
Molecular Cancer Therapeutics 16 (8), 1705-1716, 2017
Mandates: Swedish Research Council, European Commission
Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo
C de Boer, Z Armstrong, VAJ Lit, U Barash, G Ruijgrok, I Boyango, ...
Proceedings of the National Academy of Sciences 119 (31), e2203167119, 2022
Mandates: European Molecular Biology Laboratory, Netherlands Organisation for …
Biology of the heparanase–heparan sulfate axis and its role in disease pathogenesis
I Vlodavsky, U Barash, HM Nguyen, SM Yang, N Ilan
Seminars in thrombosis and hemostasis 47 (03), 240-253, 2021
Mandates: US National Science Foundation, US National Institutes of Health, National …
In vivo modulation of ubiquitin chains by N-methylated non-proteinogenic cyclic peptides
JM Rogers, M Nawatha, B Lemma, GB Vamisetti, I Livneh, U Barash, ...
RSC chemical biology 2 (2), 513-522, 2021
Mandates: US National Institutes of Health, European Commission, Agence Nationale de …
Heparanase-The message comes in different flavors
N Ilan, U Bhattacharya, U Barash, I Boyango, Y Yanku, M Gross-Cohen, ...
Heparanase: From Basic Research to Clinical Applications, 253-283, 2020
Mandates: US National Science Foundation, US National Institutes of Health
Publication and funding information is determined automatically by a computer program